health
Health & Medicine
The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.
HIGH confiance
Couverture (118 articles)
Aucune couverture n'a encore été rassemblée pour ce sujet.